Edwards Lifesciences Corporation to Participate in the RBC Capital Markets Healthcare Conference

IRVINE, CA--(Marketwire - February 24, 2010) - Edwards Lifesciences Corporation (NYSE: EW), a world leader in products and technologies to treat advanced cardiovascular disease, is scheduled to participate in the RBC Capital Markets Healthcare Conference at the New York Palace Hotel in New York, New York on Wednesday, March 3, 2010.

Thomas M. Abate, Edwards Lifesciences’ corporate vice president, chief financial officer & treasurer, is scheduled to speak to conference attendees at 10:00 a.m. EST. A live webcast of the discussion will be available to all interested parties on the Edwards Lifesciences investor relations website at http://www.edwards.com/InvestorRelations/EventCalendar.htm. An archived version of the webcast will be available later that day on the Edwards investor relations website in the News and Events section.

About Edwards Lifesciences

Edwards Lifesciences is the global leader in the science of heart valves and hemodynamic monitoring, with more than five decades of experience in partnering with clinicians to develop life-saving innovations. Headquartered in Irvine, Calif., Edwards treats advanced cardiovascular disease with its market-leading heart valve therapies, and critical care and vascular technologies, which are sold in approximately 100 countries. The company’s global brands include Carpentier-Edwards, Cosgrove-Edwards, Edwards SAPIEN, FloTrac, Fogarty, PERIMOUNT Magna and Swan-Ganz. Additional company information can be found at http://www.edwards.com.

Edwards is a trademark of Edwards Lifesciences Corporation. Edwards Lifesciences, the stylized E logo, Carpentier-Edwards, Cosgrove-Edwards, Edwards SAPIEN, FloTrac, Fogarty, PERIMOUNT Magna and Swan-Ganz are trademarks of Edwards Lifesciences Corporation and are registered in the United States Patent and Trademark Office.